logo
Overview
Discover
Watchlists
Portfolios
Heatmap
Sectors
Trendscore
Performers
Alerts
Options
Earnings
Screeners
Scanners
Backtests
Strategies
Comparisons
Charts
Sign in
Discover

CRDF
Cardiff Oncology, Inc.
1.29
2 x 0.92
2 x 1.62
bid
ask
-
0.01
0.77%
2 @ 04:00 PM
1.26 -0.03 (1.98%)
Ytd-54.09%
1y-63.25%
1.26
day range
1.30
1.16
52 week range
4.56
Open1.28Prev Close1.30Low1.26High1.30Mkt Cap88.20M
Vol564.19KAvg Vol1.21MEPS-0.67P/EN/AForward P/E-4.03
Beta1.93Short Ratio8.06Inst. Own27.66%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-0650-d Avg1.57200-d Avg1.991yr Est10.75

CRDF News

benzinga.com
Craig-Hallum Downgrades Cardiff Oncology to Hold, Lowers Price Target to $2

Craig-Hallum analyst Albert Lowe downgrades Cardiff Oncology (NASDAQ:CRDF) from Buy to Hold and l

benzinga.com
Cardiff Oncology Announces Presentation Of Phase 2 Trial Data For RAS-Mutated mCRC Treatment Onvanse

Data Highlights from the ongoing Phase 2 trial (Data cut: March 18, 2026):In the intent-to-treat (IT

This Craig-Hallum Analyst Turns Bearish; Here Are Top 5 Downgrades For Monday
benzinga.com
This Craig-Hallum Analyst Turns Bearish; Here Are Top 5 Downgrades For Monday

Analysts downgraded ratings on Cardiff Oncology, Crescent Biopharma, Corsair Gaming, Equity Resident